169 related articles for article (PubMed ID: 19110031)
1. Cell-specific loss of kappa-opioid receptors in oligodendrocytes of the dysmyelinating jimpy mouse.
Knapp PE; Adjan VV; Hauser KF
Neurosci Lett; 2009 Feb; 451(2):114-8. PubMed ID: 19110031
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of apoptotic markers in jimpy and in Plp overexpressors: evidence for different apoptotic pathways.
Cerghet M; Bessert DA; Nave KA; Skoff RP
J Neurocytol; 2001; 30(9-10):841-55. PubMed ID: 12165674
[TBL] [Abstract][Full Text] [Related]
3. Astrocytic hypertrophy in dysmyelination influences the diffusion anisotropy of white matter.
Harsan LA; Poulet P; Guignard B; Parizel N; Skoff RP; Ghandour MS
J Neurosci Res; 2007 Apr; 85(5):935-44. PubMed ID: 17278151
[TBL] [Abstract][Full Text] [Related]
4. Endogenous opioid system in developing normal and jimpy oligodendrocytes: mu and kappa opioid receptors mediate differential mitogenic and growth responses.
Knapp PE; Maderspach K; Hauser KF
Glia; 1998 Feb; 22(2):189-201. PubMed ID: 9537839
[TBL] [Abstract][Full Text] [Related]
5. Pelizaeus-Merzbacher disease: pathogenic mechanisms and insights into the roles of proteolipid protein 1 in the nervous system.
Garbern JY
J Neurol Sci; 2005 Feb; 228(2):201-3. PubMed ID: 15694206
[No Abstract] [Full Text] [Related]
6. Chemical Screening Identifies Enhancers of Mutant Oligodendrocyte Survival and Unmasks a Distinct Pathological Phase in Pelizaeus-Merzbacher Disease.
Elitt MS; Shick HE; Madhavan M; Allan KC; Clayton BLL; Weng C; Miller TE; Factor DC; Barbar L; Nawash BS; Nevin ZS; Lager AM; Li Y; Jin F; Adams DJ; Tesar PJ
Stem Cell Reports; 2018 Sep; 11(3):711-726. PubMed ID: 30146490
[TBL] [Abstract][Full Text] [Related]
7. The PLP mutants from mouse to man.
Duncan ID
J Neurol Sci; 2005 Feb; 228(2):204-5. PubMed ID: 15694207
[No Abstract] [Full Text] [Related]
8. The early phenotype associated with the jimpy mutation of the proteolipid protein gene.
Thomson CE; Anderson TJ; McCulloch MC; Dickinson P; Vouyiouklis DA; Griffiths IR
J Neurocytol; 1999 Mar; 28(3):207-21. PubMed ID: 10617903
[TBL] [Abstract][Full Text] [Related]
9. Processing of PLP in a model of Pelizaeus-Merzbacher disease/SPG2 due to the rumpshaker mutation.
McLaughlin M; Barrie JA; Karim S; Montague P; Edgar JM; Kirkham D; Thomson CE; Griffiths IR
Glia; 2006 May; 53(7):715-22. PubMed ID: 16506223
[TBL] [Abstract][Full Text] [Related]
10. Programmed cell death without DNA fragmentation in the jimpy mouse: secreted factors can enhance survival.
Knapp PE; Bartlett WP; Williams LA; Yamada M; Ikenaka K; Skoff RP
Cell Death Differ; 1999 Feb; 6(2):136-45. PubMed ID: 10200560
[TBL] [Abstract][Full Text] [Related]
11. [New role of Cdk5 in oligodendrocyte development and dysmyelinating disorders of the central nervous system].
Miyamoto Y; Yamauchi J
Seikagaku; 2011 Apr; 83(4):320-3. PubMed ID: 21626886
[No Abstract] [Full Text] [Related]
12. Evidence that CNS hypomyelination does not cause death of jimpy-msd mutant mice.
Billings-Gagliardi S; Nunnari JN; Nadon NL; Wolf MK
Dev Neurosci; 1999; 21(6):473-82. PubMed ID: 10640865
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of defective jimpy oligodendrocytes in culture.
Feutz AC; Bellomi I; Allinquant B; Schladenhaufen Y; Ghandour MS
J Neurocytol; 1995 Nov; 24(11):865-77. PubMed ID: 8576715
[TBL] [Abstract][Full Text] [Related]
14. Trafficking of PLP/DM20 and cAMP signaling in immortalized jimpy oligodendrocytes.
Ghandour MS; Feutz AC; Jalabi W; Taleb O; Bessert D; Cypher M; Carlock L; Skoff RP
Glia; 2002 Dec; 40(3):300-11. PubMed ID: 12420310
[TBL] [Abstract][Full Text] [Related]
15. Dysmyelination and reduced myelin basic protein gene expression by oligodendrocytes of SHP-1-deficient mice.
Massa PT; Wu C; Fecenko-Tacka K
J Neurosci Res; 2004 Jul; 77(1):15-25. PubMed ID: 15197735
[TBL] [Abstract][Full Text] [Related]
16. Quantitative proton MRS of Pelizaeus-Merzbacher disease: evidence of dys- and hypomyelination.
Hanefeld FA; Brockmann K; Pouwels PJ; Wilken B; Frahm J; Dechent P
Neurology; 2005 Sep; 65(5):701-6. PubMed ID: 16157902
[TBL] [Abstract][Full Text] [Related]
17. Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene.
Kagawa T; Ikenaka K; Inoue Y; Kuriyama S; Tsujii T; Nakao J; Nakajima K; Aruga J; Okano H; Mikoshiba K
Neuron; 1994 Aug; 13(2):427-42. PubMed ID: 7520255
[TBL] [Abstract][Full Text] [Related]
18. Gene expression in the jimpy mutant: evidence for fewer oligodendrocytes expressing myelin protein genes and impaired translocation of myelin basic protein mRNA.
Verity AN; Levine MS; Campagnoni AT
Dev Neurosci; 1990; 12(6):359-72. PubMed ID: 1706246
[TBL] [Abstract][Full Text] [Related]
19. Fate of jimpy-type oligodendrocytes in jimpy heterozygote.
Kagawa T; Nakao J; Yamada M; Shimizu K; Hayakawa T; Mikoshiba K; Ikenaka K
J Neurochem; 1994 May; 62(5):1887-93. PubMed ID: 7512620
[TBL] [Abstract][Full Text] [Related]
20. GJA12 mutations are a rare cause of Pelizaeus-Merzbacher-like disease.
Henneke M; Combes P; Diekmann S; Bertini E; Brockmann K; Burlina AP; Kaiser J; Ohlenbusch A; Plecko B; Rodriguez D; Boespflug-Tanguy O; Gärtner J
Neurology; 2008 Mar; 70(10):748-54. PubMed ID: 18094336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
